Extended Data Fig. 9: Controls for BRD4 degradation monitoring by immunofluorescence.
From: Targeted degradation via direct 26S proteasome recruitment
Quantitated fluorescence signals form HEK 293 cells treated with L-CIDE, D-CIDE, bench mark degrader MZ1, DMSO. Control condition lacking BRD4 primary antibody (minus BRD4 Antibody, gold) shows the background fluorescence from secondary antibody. Bars represent mean of two technical replicates.
